What is the ticker symbol for Kyverna Therapeutics?

Kyverna Therapeutics trades under the ticker KYTX on NASDAQ.

What sector does Kyverna Therapeutics operate in?

Kyverna Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze KYTX in a portfolio?

PortView shows KYTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Kyverna Therapeutics (KYTX) Stock Analysis

NASDAQHealthcareBiotechnology

$8.46+1.32%

1-year price historyRange $3.63 – $11.25

52-week range$8.46

$3.55$13.67

What Kyverna Therapeutics does

Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and lupus nephritis, as well as multiple sclerosis and systemic sclerosis. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.

Key metrics

Market cap

$514.33M

P/E (TTM)

-2.88

EPS (TTM)

$-2.94

Beta

1.94

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$8.19

200-day avg

$8.41

52-week high

$13.67

52-week low

$3.55

CEO

Warner Biddle

ETFs linked to KYTX

Broad-market and Healthcare sector ETFs an investor holding Kyverna Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how KYTX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze KYTX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Kyverna Therapeutics?: Kyverna Therapeutics trades under the ticker KYTX on NASDAQ.
Which exchange is KYTX listed on?: KYTX is listed on NASDAQ.
What sector does Kyverna Therapeutics operate in?: Kyverna Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze KYTX in a portfolio?: PortView shows KYTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.